Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Cell Centers of Idaho was a regenerative medicine clinic based in Coeur d'Alene, Idaho, that specialized in non-FDA-approved stem cell treatments for chronic pain and degenerative conditions. Founded in 2015 by Travis and Emily Autor, the clinic offered therapies utilizing adipose-derived, bone marrow-derived, and amniotic-derived stem cells, as well as platelet-rich plasma (PRP). The company targeted a wide range of indications, including neuropathy, osteoarthritis, joint pain, and chronic obstructive pulmonary disease (COPD), often marketing through public seminars. However, the business faced significant legal scrutiny, including lawsuits from the attorneys general of Iowa and Nebraska for alleged consumer fraud and deceptive marketing. These legal challenges and regulatory pressure from the FDA regarding unproven regenerative treatments ultimately led to the cessation of many of its operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Cell Centers of Idaho.